Related Experiment Video
Updated: Sep 23, 2025
08:17
Direct Intrathecal Injection of Recombinant Adeno-associated Viruses in Adult Mice
Published on: February 15, 2019
37.8K
Commentary: Aducanumab-Related ARIA: Paean or Lament?
Heidi R Wassef1, Patrick M Colletti
1From the Department of Radiology, Keck School of Medicine of USC, Los Angeles, CA.
Clinical Nuclear Medicine
|May 11, 2022
Summary
This study discusses amyloid PET imaging and Alzheimer disease diagnosis, exploring new methods for early detection and effective prevention strategies. It addresses the implications of aducanumab, an antiamyloid therapy, for future Alzheimer disease management.
Area of Science:
- Neurology
- Neuroimaging
- Pharmacology
Background:
- Recent advancements in amyloid positron emission tomography (PET) and the approval of aducanumab, an antiamyloid treatment, necessitate a re-evaluation of Alzheimer disease (AD) diagnosis and management.
- Høilund-Carlsen et al. highlight critical considerations regarding these developments.
Purpose of the Study:
- To discuss emerging developments in Alzheimer disease research.
- To explore novel methods for the presymptomatic detection of Alzheimer disease.
- To consider the development of effective prevention and therapeutic strategies for Alzheimer disease.
Main Methods:
- Literature review and discussion of current research trends.
- Analysis of the role of amyloid PET in Alzheimer disease diagnosis.
- Evaluation of the clinical implications of antiamyloid therapies.
Main Results:
- Emerging technologies may enable earlier detection of Alzheimer disease pathology.
- New therapeutic avenues are being explored for Alzheimer disease prevention and treatment.
- The integration of amyloid PET and novel therapies like aducanumab presents both opportunities and challenges.
Conclusions:
- Continued research into presymptomatic detection is crucial for effective Alzheimer disease intervention.
- The development of targeted prevention and therapy strategies holds promise for managing Alzheimer disease.
- A comprehensive approach integrating diagnostics and therapeutics is essential for advancing Alzheimer disease care.
